NASDAQ
FONR

Fonar Corporation

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Fonar Corporation Stock Price

Vitals

Today's Low:
$15.9
Today's High:
$16.09
Open Price:
$15.9
52W Low:
$13.28
52W High:
$19
Prev. Close:
$16.05
Volume:
4571

Company Statistics

Market Cap.:
$106.99 million
Book Value:
23.58
Revenue TTM:
$97.68 million
Operating Margin TTM:
16.84%
Gross Profit TTM:
$47.01 million
Profit Margin:
10.63%
Return on Assets TTM:
5.21%
Return on Equity TTM:
9.22%

Company Profile

Fonar Corporation had its IPO on 1987-01-01 under the ticker symbol FONR.

The company operates in the Healthcare sector and Diagnostics & Research industry. Fonar Corporation has a staff strength of 484 employees.

Stock update

Shares of Fonar Corporation opened at $15.9 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $15.9 - $16.09, and closed at $15.92.

This is a -0.81% slip from the previous day's closing price.

A total volume of 4,571 shares were traded at the close of the day’s session.

In the last one week, shares of Fonar Corporation have slipped by -2.81%.

Fonar Corporation's Key Ratios

Fonar Corporation has a market cap of $106.99 million, indicating a price to book ratio of 0.7668 and a price to sales ratio of 1.2026.

In the last 12-months Fonar Corporation’s revenue was $97.68 million with a gross profit of $47.01 million and an EBITDA of $20.80 million. The EBITDA ratio measures Fonar Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Fonar Corporation’s operating margin was 16.84% while its return on assets stood at 5.21% with a return of equity of 9.22%.

In Q1, Fonar Corporation’s quarterly earnings growth was a positive 68.9% while revenue growth was a positive 3.5%.

Fonar Corporation’s PE and PEG Ratio

Forward PE
0
Trailing PE
10.9184
PEG
0

Its diluted EPS in the last 12-months stands at $1.47 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Fonar Corporation’s profitability.

Fonar Corporation stock is trading at a EV to sales ratio of 1.0942 and a EV to EBITDA ratio of 3.6034. Its price to sales ratio in the trailing 12-months stood at 1.2026.

Fonar Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$199.34 million
Total Liabilities
$13.93 million
Operating Cash Flow
$-2204000.00
Capital Expenditure
$2.20 million
Dividend Payout Ratio
0%

Fonar Corporation ended 2024 with $199.34 million in total assets and $0 in total liabilities. Its intangible assets were valued at $199.34 million while shareholder equity stood at $157.18 million.

Fonar Corporation ended 2024 with $1.23 million in deferred long-term liabilities, $13.93 million in other current liabilities, 1000.00 in common stock, $-25428000.00 in retained earnings and $4.27 million in goodwill. Its cash balance stood at $49.64 million and cash and short-term investments were $49.67 million. The company’s total short-term debt was $4,241,000 while long-term debt stood at $126000.00.

Fonar Corporation’s total current assets stands at $122.00 million while long-term investments were $0 and short-term investments were $32000.00. Its net receivables were $68.50 million compared to accounts payable of $1.72 million and inventory worth $2.66 million.

In 2024, Fonar Corporation's operating cash flow was $-2204000.00 while its capital expenditure stood at $2.20 million.

Comparatively, Fonar Corporation paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$15.92
52-Week High
$19
52-Week Low
$13.28
Analyst Target Price
$

Fonar Corporation stock is currently trading at $15.92 per share. It touched a 52-week high of $19 and a 52-week low of $19. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $16.71 and 200-day moving average was $16.98 The short ratio stood at 1.42 indicating a short percent outstanding of 0%.

Around 365.6% of the company’s stock are held by insiders while 4698% are held by institutions.

Frequently Asked Questions About Fonar Corporation

The stock symbol (also called stock or share ticker) of Fonar Corporation is FONR

The IPO of Fonar Corporation took place on 1987-01-01

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
$235.65
-9.5
-3.88%
$251.31
-3.46
-1.36%
GATI LTD. (GATI)
$160.2
-0.4
-0.25%
$24.21
0.02
+0.08%
$420
-3.1
-0.73%
$6.85
-0.05
-0.72%
$0.03
0
+3.45%
$181.8
-0.5
-0.27%
$16.18
0.44
+2.76%
$59.4
0.35
+0.59%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 41 MRI scanning facilities, including 26 facilities located in New York and 15 facilities located in Florida. The company markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Address

110 Marcus Drive, Melville, NY, United States, 11747